The market for psychedelic drugs to treat mental health conditions gets a big buy signal
Psilocybin mushrooms stand ready for harvest in a humidified “fruiting chamber.” John Moore | Getty Images Thursday’s announcement that Eli …
Biotech and Pharmaceuticals
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
Michael Siluk | UCG | Universal Images Group | Getty Images Losing weight with GLP-1 drugs is only half the …
Medicare will start covering obesity drugs for the first time. Here’s what patients should know
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity …
As the largest World Cup ever kicks off, health officials are focused on more than Ebola
As athletes and millions of fans gear up for the FIFA World Cup starting next week, global health officials are …
Hantavirus outbreak isn’t another Covid pandemic – but experts say it’s testing U.S. readiness
A cruise ship outbreak of hantavirus has rattled the public and reignited fears of another global health scare as passengers …
Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs
Pharma thinks it’s found the next frontier in preventing heart attacks. Novartis, Amgen and Eli Lilly are among the drugmakers …
Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era
Boxes of medication are seen on the shelves of the Keencare pharmacy, a member of the Green Light Group, on …
Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment
After years of trying to lose weight “the right way,” Jane Zuckerman realized that “putting in the work just wasn’t …
The price of menstrual products is skyrocketing from inflation, tariffs
Always products are displayed on a shelf in a supermarket in Sarajevo, Bosnia and Herzegovina October 29, 2024. Dado Ruvic …
Here’s an update on our 4th Industrial Revolution stocks and the rest of the portfolio
On Friday, the CNBC Investing Club held its February Monthly Meeting, where Jim Cramer and Director of Portfolio Analysis ran …